Within different glioma types, EIF4EBP1 expression is found to be higher in the most aggressive CNS World Health Organisation (WHO) grade 4 glioblastoma, followed by grade 3 and grade 2 gliomas (Fig. 6B). This evidence concerns the gene EIF4EBP1 and central nervous system cancer.